ONCO (STOCKS)
Onconetix, Inc. Common Stock
$0.815600
-0.274400 (-25.17%)
Prev close: $1.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Allan White
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $0.58M
- Employees
- 5
- P/E (TTM)
- —
- P/B (TTM)
- 0.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$0.25 | $0.00 | +0.0000 | +0.00% |
|
Sep 2023 (Q3)
|
$-4,590.00 | $-3,294.60 | -1,295.4000 | -39.32% |
|
Jun 2023 (Q2)
|
$-3,570.00 | $-2,601.00 | -969.0000 | -37.25% |
|
Mar 2023 (Q1)
|
$-3,060.00 | $-3,641.40 | +581.4000 | +15.97% |
Financial Statements
| Revenues | $815.37K |
| Benefits Costs and Expenses | $14.85M |
| Cost Of Revenue | $182.46K |
| Costs And Expenses | $35.00K |
| Gross Profit | $632.91K |
| Nonoperating Income/Loss | $3.83M |
| Operating Expenses | $18.49M |
| Selling, General, and Administrative Expenses | $7.04M |
| Depreciation and Amortization | $15.17K |
| Other Operating Expenses | $11.43M |
| Operating Income/Loss | -$17.86M |
| Income/Loss From Continuing Operations After Tax | -$14.03M |
| Income/Loss From Continuing Operations Before Tax | -$14.03M |
| Income Tax Expense/Benefit | $525.00 |
| Net Income/Loss | -$14.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.50M |
| Preferred Stock Dividends And Other Adjustments | $1.50M |
| Basic Earnings Per Share | -$16.56 |
| Diluted Earnings Per Share | -$16.56 |
| Basic Average Shares | 937,690 |
| Diluted Average Shares | 937,690 |
| Assets | $24.93M |
| Current Assets | $6.07M |
| Inventory | $149.96K |
| Other Current Assets | $5.92M |
| Noncurrent Assets | $18.86M |
| Fixed Assets | $37.09K |
| Other Non-current Assets | $18.82M |
| Liabilities | $9.16M |
| Current Liabilities | $9.14M |
| Accounts Payable | $1.76M |
| Other Current Liabilities | $7.38M |
| Noncurrent Liabilities | $24.36K |
| Equity | $15.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.76M |
| Liabilities And Equity | $24.93M |
| Net Cash Flow From Operating Activities | -$9.68M |
| Net Cash Flow From Operating Activities, Continuing | -$9.68M |
| Net Cash Flow From Investing Activities | -$4.57M |
| Net Cash Flow From Investing Activities, Continuing | -$4.77M |
| Net Cash Flow From Financing Activities | $14.45M |
| Net Cash Flow From Financing Activities, Continuing | $14.45M |
| Exchange Gains/Losses | -$200.14K |
| Net Cash Flow | $200.14K |
| Net Cash Flow, Continuing | $400.28K |
| Comprehensive Income/Loss | -$11.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.20M |
| Other Comprehensive Income/Loss | -$11.20M |